In a groundbreaking study published in the prestigious Proceedings of the National Academy of Sciences, researchers from Cornell University have harnessed the unique genetic makeup of purebred dogs to unravel the complex genetics underlying gastric cancer. This rare condition in dogs mirrors many aspects of the human disease, presenting typically with subtle clinical symptoms, poor prognosis, and a variety of tumor subtypes. Such parallels, combined with the genetic homogeneity often found in specific dog breeds, make canines an exceptional natural model for advancing cancer genomics and potential therapeutic interventions.
The study delved deeply into the DNA of two dog breeds that exhibit a notably higher incidence of gastric cancer: the Belgian Tervuren and the Belgian sheepdog. By analyzing genomic sequences from nearly 500 dogs, including 200 diagnosed with gastric cancer and 270 healthy controls, the researchers were able to identify over 15 genomic loci associated with susceptibility to this malignancy. The relatively modest sample size contrasts strikingly with human genome-wide association studies, which typically require thousands of samples to detect comparable numbers of risk genes, underscoring the genetic advantages of using purebred dogs for such investigations.
At the heart of the research was the meticulous comparison of specific DNA base frequencies at key genome sites between affected and unaffected dogs. This approach enabled the identification of distinct genetic differences that appear to significantly influence disease risk. Among the regions flagged were well-known cancer-associated genes such as PTEN, a pivotal tumor suppressor extensively studied in human oncology, as well as novel genes like PDZRN3 that had not previously been linked to gastric cancer. These novel findings open promising new frontiers for both veterinary and human cancer research.
.adsslot_1IZLP3Ubq7{width:728px !important;height:90px !important;}
@media(max-width:1199px){ .adsslot_1IZLP3Ubq7{width:468px !important;height:60px !important;}
}
@media(max-width:767px){ .adsslot_1IZLP3Ubq7{width:320px !important;height:50px !important;}
}
ADVERTISEMENT
The involvement of multiple research institutions across North America and Europe, including Utrecht University, University of California Davis, Tufts University, and the National Human Genome Research Institute, added robust multidisciplinary expertise to the study. This collaborative effort was paramount in the collection and analysis of genetic samples, which were sourced over several years via a concerted effort from dog owners, breeders, and veterinarians. Such a collaborative network highlights the growing importance of cross-institutional partnerships in tackling complex genetic diseases.
One particularly illuminating aspect of the study involved the comparison with a genetically related breed, the Belgian Malinois, which rarely develops gastric cancer. By contrasting the DNA of Malinois dogs with that of the more susceptible breeds, researchers discovered three genomic regions potentially conferring protective effects. Two of these loci were uniquely enriched in the Malinois and appeared more frequently among healthy controls in the study population, suggesting a heritable element of resistance that could prove invaluable in designing genetic screening tools.
These insights carry profound implications for canine health management. Currently, gastric cancer in dogs is often diagnosed too late for effective therapeutic intervention, mirroring the diagnostic challenges faced in human medicine. However, the identification of genetic risk factors paves the way for early detection through genetic testing. Screening high-risk dogs before clinical signs emerge holds the promise of timely and potentially life-saving treatment, transforming the prognosis for affected animals.
Beyond early diagnosis, the study’s findings also lay the groundwork for informed breeding practices aimed at reducing the prevalence of gastric cancer in susceptible breeds. By integrating genetic risk profiling into breeding decisions, breeders can minimize the frequency of harmful alleles, ultimately fostering healthier canine populations. Moreover, targeted molecular therapies could emerge from the genes and pathways identified, hopping across species barriers to benefit both canine and human patients in the future.
The Cornell research team is actively expanding its sample collection to validate their genetic markers and refine predictive models. They are also investigating gene expression patterns within tumor tissues to identify dysregulated genes that may serve as therapeutic targets. This dual focus on germline susceptibility and somatic tumor biology exemplifies a comprehensive approach to understanding gastric cancer’s etiology and progression.
Such canine models hold particular allure in cancer biology because purebred dogs exhibit limited genetic diversity within breeds, which magnifies the signal of disease-associated genes against the background genetic noise. This contrasts with the extensive heterogeneity in human populations, where millions of polymorphisms can obscure true risk signals. Therefore, canine genomics offers an accelerated path for discovery, rapidly pinpointing genes and pathways that can be further investigated in human studies.
The study was supported by the Cornell Richard P. Riney Canine Health Center, the National Human Genome Research Institute’s intramural program, and Belgian shepherd dog breed clubs across America and Europe, showcasing the vital role of institutional and community backing in advancing scientific endeavors. This funding and support infrastructure was crucial in enabling such an extensive and rigorous investigation into canine gastric cancer genetics.
In sum, this research represents a major leap forward in understanding the genetic architecture of gastric cancer through the lens of naturally occurring disease in dogs. The identification of both previously known and novel cancer risk loci not only reinforces the biological similarities between canine and human gastric cancers but also sets the stage for translational applications that could save lives across species. As these findings gain traction, they underscore the powerful synergy between veterinary science and human medicine, heralding a new era of comparative oncology research.
Subject of Research: Genetic susceptibility to gastric cancer in purebred dogs and its implications for human disease.
Article Title: Genomic analyses identify 15 risk loci and reveal HDAC2, SOX2-OT, and IGF2BP2 in a naturally occurring canine model of gastric cancer
News Publication Date: 30-May-2025
Web References:
http://www.pnas.org/doi/10.1073/pnas.2416723122
https://news.cornell.edu/stories/2025/04/dog-owners-help-advance-research-one-dna-test-time
References:
Evans, J., Cook, S., Hayward, J., et al. (2025). Genomic analyses identify 15 risk loci and reveal HDAC2, SOX2-OT, and IGF2BP2 in a naturally occurring canine model of gastric cancer. Proc Natl Acad Sci U S A. DOI:10.1073/pnas.2416723122
Keywords: Dogs, Gastric Cancer, Cancer Genetics, Veterinary Oncology, Purebred Dogs, Genetic Susceptibility, Comparative Oncology, PTEN, PDZRN3, Genomic Loci, Early Diagnosis, Genetic Testing
Tags: Belgian sheepdog cancer susceptibilityBelgian Tervuren gastric cancercancer genomics advancementscanine health and geneticsdog genetics and human cancergastric cancer research in dogsgenetic model for human diseasesgenomic loci in cancer researchimplications for human gastric cancer treatmentpurebred dog genetics in cancer studiesrare cancers in dogsveterinary genetics and human health
